152 related articles for article (PubMed ID: 27196263)
1. Current physico-biochemistry in steroid research and status of structural biology for steroid-converting enzymes.
Lin SX; Shi R; Hu XJ; Penning TM
J Steroid Biochem Mol Biol; 2016 Jul; 161():1-4. PubMed ID: 27196263
[No Abstract] [Full Text] [Related]
2. [Importance of the 11β-hydroxysteroid dehydrogenase enzyme in clinical disorders].
Feldman K; Likó I; Nagy Z; Szappanos A; Grolmusz VK; Tóth M; Rácz K; Patócs A
Orv Hetil; 2013 Feb; 154(8):283-93. PubMed ID: 23419529
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
Yang H; Dou W; Lou J; Leng Y; Shen J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
[TBL] [Abstract][Full Text] [Related]
5. Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
Bydal P; Luu-The V; Labrie F; Poirier D
Eur J Med Chem; 2009 Feb; 44(2):632-44. PubMed ID: 18472187
[TBL] [Abstract][Full Text] [Related]
6. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
Roche D; Carniato D; Leriche C; Lepifre F; Christmann-Franck S; Graedler U; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
Bioorg Med Chem Lett; 2009 May; 19(10):2674-8. PubMed ID: 19395260
[TBL] [Abstract][Full Text] [Related]
8. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
Lee JH; Kang NS; Yoo SE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model.
Julian LD; Wang Z; Bostick T; Caille S; Choi R; DeGraffenreid M; Di Y; He X; Hungate RW; Jaen JC; Liu J; Monshouwer M; McMinn D; Rew Y; Sudom A; Sun D; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
J Med Chem; 2008 Jul; 51(13):3953-60. PubMed ID: 18553955
[TBL] [Abstract][Full Text] [Related]
10. Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold.
Lepifre F; Christmann-Franck S; Roche D; Leriche C; Carniato D; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
Bioorg Med Chem Lett; 2009 Jul; 19(13):3682-5. PubMed ID: 19450980
[TBL] [Abstract][Full Text] [Related]
11. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333
[TBL] [Abstract][Full Text] [Related]
12. [Interaction of steroid hormones with their target cells].
Baulieu EE
Reprod Nutr Dev (1980); 1980; 20(2):419-41. PubMed ID: 6296936
[No Abstract] [Full Text] [Related]
13. The selectivity of tyrosine 280 of human 11beta-hydroxysteroid dehydrogenase type 1 in inhibitor binding.
Kim KW; Wang Z; Busby J; Tsuruda T; Chen M; Hale C; Castro VM; Svensson S; Nybo R; Xiong F; Wang M
FEBS Lett; 2007 Mar; 581(5):995-9. PubMed ID: 17306259
[TBL] [Abstract][Full Text] [Related]
14. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity.
Kousteni S; Bellido T; Plotkin LI; O'Brien CA; Bodenner DL; Han L; Han K; DiGregorio GB; Katzenellenbogen JA; Katzenellenbogen BS; Roberson PK; Weinstein RS; Jilka RL; Manolagas SC
Cell; 2001 Mar; 104(5):719-30. PubMed ID: 11257226
[TBL] [Abstract][Full Text] [Related]
15. Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1).
Wang H; Robl JA; Hamann LG; Simpkins L; Golla R; Li YX; Seethala R; Zvyaga T; Gordon DA; Li JJ
Bioorg Med Chem Lett; 2011 Jul; 21(14):4146-9. PubMed ID: 21689935
[TBL] [Abstract][Full Text] [Related]
16. Biochemical properties of human dehydrogenase/reductase (SDR family) member 7.
Stambergova H; Skarydova L; Dunford JE; Wsol V
Chem Biol Interact; 2014 Jan; 207():52-7. PubMed ID: 24246760
[TBL] [Abstract][Full Text] [Related]
17. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor.
Hale C; Véniant M; Wang Z; Chen M; McCormick J; Cupples R; Hickman D; Min X; Sudom A; Xu H; Matsumoto G; Fotsch C; St Jean DJ; Wang M
Chem Biol Drug Des; 2008 Jan; 71(1):36-44. PubMed ID: 18069989
[TBL] [Abstract][Full Text] [Related]
19. Diazepane-acetamide derivatives as selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
Odermatt A
Expert Opin Ther Pat; 2009 Oct; 19(10):1477-83. PubMed ID: 19780703
[TBL] [Abstract][Full Text] [Related]
20. Development and application of a scintillation proximity assay (SPA) for identification of selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
Mundt S; Solly K; Thieringer R; Hermanowski-Vosatka A
Assay Drug Dev Technol; 2005 Aug; 3(4):367-75. PubMed ID: 16180991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
